WEIGHT LOSS STUDY – Copy

WEIGHT LOSS STUDY -Currently on enrollment hold Age: 21-70 Condition: Overweight patients with a BMI of 30-45 who will be provided tirzepatide to lose 15% of your body weight. To follow, an upper GI endoscopy with a groundbreaking procedure called a DMR to see if it will help maintain your weight loss. (Can not be…

Type 2 Diabetic, Non-Drug Procedure

TYPE 2 DIABETIC with Uncontrolled blood sugars using Semaglutide or Tirzepatide Age: 18-75  Condition: Uncontrolled, Type 2 Diabetics currently using Semaglutide or Tirzepatide for at least 3 months. A1c 7.5-10.5. 

ENDOMETRIOSIS

ENDOMETRIOSIS – WOMAN Age: 18-49 Condition: Endometriosis with Moderate to Severe pain in premenopausal women9